Dental Anesthesia Market Component, Technology and Major Market Players

Posted by vinit sawant on February 5th, 2021

According to the World Health Organization (WHO), around 60% to 90% of children suffer from any dental issues, which augments demand for dental anesthesia.

Additionally, an increasing number of approvals or clinical trials by the U.S. Food and Drugs Administration (FDA) is estimated to benefit market growth in the coming future. The other factors, such as raising awareness toward oral health and continuous dental health checkups, advanced drug administration devices, and the economic growth of the mid-earning people globally, are driving growth of the global dental anesthetic market.

However, stringent regulatory norms and the possibility of the side effects due to anesthetic drugs are restraining growth of the global dental anesthetic market. Nonetheless, increasing investment for exploration for newer medications, which comply with the more modern regulations implicated by WHO and FDA, are estimated to offer opportunities during the estimated timeframe.

Competitive Analysis:

Some of the key players in the global dental anesthesia market include Astra Zeneca, Dentsply, Septodont, Sirona, Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson & Johnson, Baxter International Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hikma Pharmaceuticals PLC, Hospira, Inc., AbbVie Inc., and Fresenius Se & Co. Kgaa.